Concomitant Psychiatric and Nonalcohol-Related Substance Use Disorders Among Hospitalized Patients with Alcoholic Liver Disease in the United States.
Concomitant Psychiatric and Nonalcohol-Related Substance Use Disorders Among Hospitalized Patients with Alcoholic Liver Disease in the United States.
复制标题
在美国,住院患者的酒精性肝病患者中,伴随精神病和非酒精相关药物使用障碍。
DOI:
10.1111/acer.13567
复制
发表时间:
2018-03
期刊:
影响因子:
--
通讯作者:
Translational Research and Evolving Alcoholic Hepatitis Treatment Consortium
中科院分区:
文献类型:
--
作者:
Jinjuvadia R;Jinjuvadia C;Puangsricharoen P;Chalasani N;Crabb DW;Liangpunsakul S;Translational Research and Evolving Alcoholic Hepatitis Treatment Consortium
Despite that the epidemiological studies on the comorbidity of alcohol misuse and psychiatric disorders have been studied, less is known about the magnitude of these disorders among patients with alcoholic liver disease (ALD). Our aim was to determine the prevalence of psychiatric and substance use disorders among hospitalized ALD patients in the US. We utilized a single level clinical classification software to identify patients with ALD and psychiatric/substance use disorders from the 2011 National Inpatient Sample data. The primary outcome was the prevalence of these disorders among hospitalized patients with ALD (n=74,972) compared to those with chronic liver diseasesnot caused by alcohol (n=350,140) and those without underlying liver diseases (n=1,447,063). The prevalence of adjustment disorder, anxiety disorder, post-traumatic stress disorder and depression was significantly higher among hospitalized patients with ALD when compared to those with chronic liver diseases not caused by alcohol (all with p values <0.05). Younger age, female gender, and White race were the independent predictors of psychiatric/substance use disorders among hospitalized patients with ALD. Hospitalized patients with ALD have significantly high prevalence of concomitant psychiatric and substance abuse disorders when compared to those with chronic liver diseases not caused by alcohol and those without underlying liver diseases. Screening and appropriate intervention should be implemented as part of routine clinical care for these patients.
登录
查看更多内容
影响因子:
25.7
作者:
Veldt, BJ;Lainé, F;Moirand, R
通讯作者:
Moirand, R
影响因子:
168.9
作者:
TELI, MR;DAY, CP;JAMES, OFW
通讯作者:
JAMES, OFW
影响因子:
4.6
作者:
Cuadrado, A;Fábrega, E;Pons-Romero, F
通讯作者:
Pons-Romero, F
DOI:
10.15288/jsa.1988.49.219
发表时间:
1988-05-01
期刊:
JOURNAL OF STUDIES ON ALCOHOL
影响因子:
--
作者:
HELZER, JE;PRYZBECK, TR
通讯作者:
PRYZBECK, TR
影响因子:
4.6
作者:
Dew, Mary Amanda;DiMartini, Andrea F.;Greenhouse, Joel
通讯作者:
Greenhouse, Joel